Phase I study of terameprocol in patients with recurrent high-grade glioma

Terameprocol is a global transcription inhibitor that affects cell division apoptosis, drug resistance, hypoxia responsive genes, and radiation resistance in hypoxia. A multicenter, dose-escalation study was conducted in heavily pretreated patients with recurrent, measurable, high-grade gliomas. Ter...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Grossman, Stuart A., Ye, Xiaobu, Peereboom, David, Rosenfeld, Myrna R., Mikkelsen, Tom, Supko, Jeffrey G., Desideri, Serena
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2012
Konular:
Clinical Investigations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3309850/
https://ncbi.nlm.nih.gov/pubmed/22323663
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nor230
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller